公开(公告)号：EP1481093A2

公开(公告)日：2004-12-01

申请号：EP03735115.2

申请日：2003-02-03

申请人： Beth Israel Deaconess Medical Center, Inc.

发明人： CANTLEY, Lewis, C. ,  LAMIA, Katja, A. ,  RAMEH, Lucia ,  Kahn, Barbara,c/o Beth Israel Deaconess Med. ,  PERONI, Odile,Beth Israel Deaconess Med. Center

IPC分类号： C12Q1/68 ,  A01N43/04 ,  C07H21/04 ,  A61K31/07

CPC分类号： A61K49/0008 ,  A01K67/0276 ,  A01K2217/075 ,  A01K2227/105 ,  A01K2267/0325 ,  A61K38/00 ,  C12N9/1205 ,  C12N15/8509 ,  C12Q1/485 ,  G01N33/573

摘要： The invention provides methods for modulating type IIβ phosphoinisitide phosphate kinase (PIPKIIβ) activity for treating PIPKIIβ-associated disorders. The invention also provides methods of identifying candidate agents for treating PIPKIIβ-associated disorders.